Abstract
Ibandronate is a potent nitrogen-containing bisphosphonate with a tertiary amine group, which does not easily form chromophore derivatives that can be detected by UV light of fluorescence emission. Here, a simple and straightforward automated multicommutated flow system, making use of water-soluble mercaptopropionic acid-capped CdTe quantum dots, was implemented for the fluorescence quantitation of ibandronate in pharmaceutical formulations. The developed approach was based on the analyte ability to establish surface interactions that resulted in quenched nanocrystals fluorescence intensity, being this effect proportional to the target compound’s concentration. Size and concentration of quantum dots and pH of the media were some of the most relevant and influencing parameters studied. The proposed methodology allowed the determination of ibandronate in the range of 20-200 µg mL-1, with good repeatability (RSD<3%) and a sampling frequency of about 70 samples per hour. The results obtained in the analysis of pharmaceuticals showed excellent agreement with those provided by the manufacturer.
Keywords: Automation, CdTe quantum dots, ibandronate, luminescence, multicommutation, nanoparticle.
Current Pharmaceutical Analysis
Title:Rapid Fluorimetric Quantitation of Ibandronate by Coupling Quantum Dots and Multicommutated Flow Injection Analysis
Volume: 9 Issue: 3
Author(s): A. Ruiz-Medina, L. Molina-Garcia, E.J. Llorent-Martinez, J.L.M. Santos and M.L. Fernandez-de Cordova
Affiliation:
Keywords: Automation, CdTe quantum dots, ibandronate, luminescence, multicommutation, nanoparticle.
Abstract: Ibandronate is a potent nitrogen-containing bisphosphonate with a tertiary amine group, which does not easily form chromophore derivatives that can be detected by UV light of fluorescence emission. Here, a simple and straightforward automated multicommutated flow system, making use of water-soluble mercaptopropionic acid-capped CdTe quantum dots, was implemented for the fluorescence quantitation of ibandronate in pharmaceutical formulations. The developed approach was based on the analyte ability to establish surface interactions that resulted in quenched nanocrystals fluorescence intensity, being this effect proportional to the target compound’s concentration. Size and concentration of quantum dots and pH of the media were some of the most relevant and influencing parameters studied. The proposed methodology allowed the determination of ibandronate in the range of 20-200 µg mL-1, with good repeatability (RSD<3%) and a sampling frequency of about 70 samples per hour. The results obtained in the analysis of pharmaceuticals showed excellent agreement with those provided by the manufacturer.
Export Options
About this article
Cite this article as:
Ruiz-Medina A., Molina-Garcia L., Llorent-Martinez E.J., Santos J.L.M. and Cordova M.L. Fernandez-de, Rapid Fluorimetric Quantitation of Ibandronate by Coupling Quantum Dots and Multicommutated Flow Injection Analysis, Current Pharmaceutical Analysis 2013; 9 (3) . https://dx.doi.org/10.2174/1573412911309030002
DOI https://dx.doi.org/10.2174/1573412911309030002 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MicroRNAs and the Warburg Effect: New Players in an Old Arena
Current Gene Therapy Meta-analysis of NFKB1-94 ATTG Ins/Del Polymorphism and Risk of Breast Cancer
Current Drug Metabolism Patented Biomarker Panels in Early Detection of Cancer
Recent Patents on Biomarkers Curcumin Suppresses Tumor Growth and Angiogenesis in Human Glioma Cells Through Modulation of Vascular Endothelial Growth Factor/ Angiopoietin-2/Thrombospondin-1 Signaling
CNS & Neurological Disorders - Drug Targets Gemini Analogs of Vitamin D
Current Topics in Medicinal Chemistry Drug Repurposing in Anticancer Reagent Development
Combinatorial Chemistry & High Throughput Screening Recent Advances in Oral Pulsatile Drug Delivery
Recent Patents on Drug Delivery & Formulation AAVs Anatomy: Roadmap for Optimizing Vectors for Translational Success
Current Gene Therapy A Screening Method for Potential Anti-pancreatic Cancer Candidate Compounds Based on Hsp90-Cdc37 Interaction Model in vitro
Letters in Drug Design & Discovery Neuroprotective Therapies for Alzheimers Disease
Current Pharmaceutical Design Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Preparation of Water-Soluble Albumin Loaded Paclitaxil Nanoparticles Using Emulsion-Solvent Evaporation Technique
Current Bioactive Compounds Infection and Anemia
Infectious Disorders - Drug Targets Dual Induction of Mitochondrial Apoptosis and Senescence in Chronic Myelogenous Leukemia by Myrtucommulone A
Anti-Cancer Agents in Medicinal Chemistry Cellular Protection and Therapeutic Potential of Tocotrienols
Current Pharmaceutical Design Recent Advances in Gene Therapy of Endometriosis
Recent Patents on DNA & Gene Sequences Inhibition of Human 5-Lipoxygenase and Anti-Neoplastic Effects by 2-Amino-1,4-Benzoquinones
Medicinal Chemistry Synthesis and Biological Activities of Some Novel 2-Amino-(5 or 7-Substituted- 2-Oxoindolin-3-Ylidene) Benzoxazole-5-Carbohydrazide Derivatives
Letters in Drug Design & Discovery A Storage Protein-Like Trypsin Inhibitor from the Moth Bean (Phaseolus acutifolius) with Antiproliferative Activity Toward Lymphoma Cells
Protein & Peptide Letters Inhibiting the Enzymes of the Endothelin and Renin-Angiotensin Systems in Cancer
Current Enzyme Inhibition